Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

NCT02043288 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: NC-6004
DRUG: Gemcitabine

Sponsor

Orient Europharma Co., Ltd.

Collaborators

[object Object]